Amyotrophic Lateral Sclerosis (ALS)
from OrphaChat — a Rare Disease Podcast Hosted by RCH
ALS is a fatal neurodegenerative disease involving motor neuron death. Diagnosis increasingly uses the Gold Coast criteria for higher sensitivity. While Relyvrio was withdrawn, treatments like Tofersen and Riluzole remain. Research now targets SOD1 and TDP-43 mutations.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of OrphaChat — a Rare Disease Podcast?
This episode is 18 minutes long.
When was this OrphaChat — a Rare Disease Podcast episode published?
This episode was published on February 4, 2026.
Can I download this OrphaChat — a Rare Disease Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.